Veracyte, Inc.
VCYT
$28.87
-$0.20-0.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 130.16M | 114.47M | 118.63M | 115.86M | 114.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 130.16M | 114.47M | 118.63M | 115.86M | 114.43M |
| Cost of Revenue | 37.73M | 32.38M | 37.07M | 33.93M | 33.61M |
| Gross Profit | 92.44M | 82.09M | 81.57M | 81.93M | 80.82M |
| SG&A Expenses | 58.57M | 53.12M | 50.81M | 48.35M | 55.10M |
| Depreciation & Amortization | 3.29M | 3.21M | 3.61M | 3.80M | 3.79M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 115.85M | 106.42M | 110.78M | 103.66M | 108.97M |
| Operating Income | 14.31M | 8.05M | 7.85M | 12.20M | 5.46M |
| Income Before Tax | 1.25M | 7.43M | 3.44M | 16.85M | 7.36M |
| Income Tax Expenses | 2.23M | 381.00K | -1.67M | 1.69M | 1.63M |
| Earnings from Continuing Operations | -980.00K | 7.05M | 5.11M | 15.16M | 5.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -980.00K | 7.05M | 5.11M | 15.16M | 5.73M |
| EBIT | 14.31M | 8.05M | 7.85M | 12.20M | 5.46M |
| EBITDA | 19.80M | 13.41M | 14.11M | 18.08M | 11.20M |
| EPS Basic | -0.01 | 0.09 | 0.07 | 0.20 | 0.07 |
| Normalized Basic EPS | 0.17 | 0.10 | 0.06 | 0.14 | 0.07 |
| EPS Diluted | -0.01 | 0.09 | 0.06 | 0.19 | 0.07 |
| Normalized Diluted EPS | 0.17 | 0.10 | 0.06 | 0.14 | 0.07 |
| Average Basic Shares Outstanding | 78.39M | 78.03M | 77.61M | 77.01M | 76.54M |
| Average Diluted Shares Outstanding | 78.39M | 80.06M | 79.91M | 78.46M | 77.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |